Inflammation

Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Cannabidiol Reduces Intestinal Inflammation throughthe Control of Neuroimmune Axis
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
The endocannabinoid system: an emerging key player in inflammation
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice
Cannabinoids, endocannabinoids, and related analogs in inflammation
Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement
Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death
Cannabinoids in clinical practice
CBD Absorption Rates for Pain and Inflammation Treatment